Request Free Sample ×
Piriformis Syndrome Market Research Report – Forecast to 2035 Infographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Piriformis Syndrome Market

ID: MRFR/Pharma/4788-HCR
100 Pages
Rahul Gotadki
Last Updated: April 06, 2026

Piriformis Syndrome Market Research Report Information By Cause (Trauma, Spasms, Others), Diagnostic Test (MRI, Others), Treatment (Medication, Physical Therapy, Others), Distribution Channel (Retail Pharmacies, Others), End-User – Forecast Till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Piriformis Syndrome Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

Piriformis Syndrome Market Summary

As per MRFR analysis, the Piriformis Syndrome Market Size was estimated at 0.268 USD Million in 2024. The Piriformis Syndrome industry is projected to grow from 0.289 in 2025 to 0.544 by 2035, exhibiting a compound annual growth rate (CAGR) of 6.59% during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Piriformis Syndrome Market is experiencing notable growth driven by increased awareness and advancements in treatment.

  • North America remains the largest market for Piriformis Syndrome, driven by heightened awareness and improved diagnostic capabilities.
  • The Asia-Pacific region is emerging as the fastest-growing market, reflecting a rising demand for effective treatment options.
  • Physical therapy continues to dominate the market segment, while medication is rapidly gaining traction as the fastest-growing segment.
  • Key market drivers include the rising incidence of Piriformis Syndrome and the growing demand for non-invasive treatments.

Market Size & Forecast

2024 Market Size 0.268 (USD Million)
2035 Market Size 0.544 (USD Million)
CAGR (2025 - 2035) 6.59%

Major Players

Medtronic (US), Johnson & Johnson (US), Stryker (US), Boston Scientific (US), Abbott Laboratories (US), Smith & Nephew (GB), Zimmer Biomet (US), DePuy Synthes (US)

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

Piriformis Syndrome Market Trends

The Piriformis Syndrome Market is currently experiencing a notable evolution, driven by a growing awareness of the condition and its impact on individuals' quality of life. This syndrome, characterized by pain in the buttocks and potential radiating discomfort down the leg, has garnered increased attention from healthcare professionals and patients alike. As a result, there is a rising demand for effective treatment options, including physical therapy, medications, and innovative surgical interventions. The market appears to be expanding as more individuals seek relief from symptoms, leading to a broader range of therapeutic solutions being developed and offered. Moreover, advancements in diagnostic techniques and a better understanding of the syndrome's underlying mechanisms are likely to enhance treatment efficacy. The integration of technology in healthcare, such as telemedicine and mobile health applications, may also play a role in improving patient access to care. As the Piriformis Syndrome Market continues to grow, stakeholders, including pharmaceutical companies and healthcare providers, are expected to adapt their strategies to meet the evolving needs of patients. This dynamic landscape suggests a promising future for the market, with potential for further innovation and improved patient outcomes.

Increased Awareness and Diagnosis

There is a growing recognition of Piriformis Syndrome among both healthcare providers and patients. This heightened awareness is leading to more accurate diagnoses and a subsequent rise in demand for treatment options. As individuals become more informed about their symptoms, they are more likely to seek medical advice, thereby driving market growth.

Advancements in Treatment Modalities

The Piriformis Syndrome Market is witnessing a shift towards more advanced treatment modalities. Innovations in physical therapy techniques, minimally invasive surgical options, and the development of targeted medications are becoming increasingly prevalent. These advancements are likely to enhance patient outcomes and satisfaction.

Integration of Technology in Care Delivery

The incorporation of technology into healthcare practices is transforming the way Piriformis Syndrome is managed. Telehealth services and mobile applications are facilitating better patient engagement and access to care. This trend may lead to improved monitoring of symptoms and treatment adherence, ultimately benefiting patients.

Piriformis Syndrome Market Drivers

Market Growth Projections

The Global Piriformis Syndrome Market Industry is projected to experience substantial growth over the next decade. With an estimated market value of 171.9 USD Million in 2024, the industry is expected to reach 330.0 USD Million by 2035. This growth trajectory suggests a compound annual growth rate of 6.11% from 2025 to 2035. Such projections indicate a robust demand for effective treatment options and highlight the increasing recognition of Piriformis Syndrome Market as a significant health concern. The market's expansion reflects the ongoing efforts to improve patient care and enhance treatment modalities.

Increased Awareness and Diagnosis

The growing awareness of Piriformis Syndrome Market among healthcare professionals and the general public is a significant driver for the Global Piriformis Syndrome Market Industry. Enhanced education and training for clinicians lead to more accurate diagnoses, which in turn encourages patients to seek treatment. Public health campaigns and resources available online contribute to this awareness, helping individuals recognize symptoms earlier. As a result, the market is likely to see an increase in demand for diagnostic tools and therapeutic interventions. This heightened awareness is expected to support the market's growth trajectory, with projections indicating a rise to 330.0 USD Million by 2035.

Integration of Telehealth Services

The integration of telehealth services into the management of Piriformis Syndrome Market is transforming the Global Piriformis Syndrome Market Industry. Telehealth offers patients convenient access to healthcare professionals, particularly for those in remote areas or with mobility challenges. This shift not only enhances patient engagement but also facilitates timely diagnosis and treatment. As telehealth continues to gain traction, it is likely to expand the reach of healthcare providers and improve patient outcomes. The ongoing evolution of telehealth services may further stimulate market growth, as more patients utilize these platforms for managing their conditions.

Advancements in Treatment Modalities

Innovations in treatment options for Piriformis Syndrome Market are propelling the Global Piriformis Syndrome Market Industry forward. Recent advancements include minimally invasive surgical techniques, physical therapy, and the use of targeted injections. These developments enhance patient outcomes and reduce recovery times, making treatment more appealing. Furthermore, the introduction of new therapeutic devices and medications is likely to improve the management of this condition. As the market evolves, it is anticipated that the Global Piriformis Syndrome Market will experience a compound annual growth rate of 6.11% from 2025 to 2035, driven by these advancements.

Rising Prevalence of Piriformis Syndrome

The increasing incidence of Piriformis Syndrome Market is a notable driver for the Global Piriformis Syndrome Market Industry. Factors such as sedentary lifestyles and the growing aging population contribute to this trend. Reports indicate that the prevalence of this condition is rising, particularly among individuals engaged in repetitive activities or prolonged sitting. As awareness of this syndrome grows, more patients seek medical intervention, thereby expanding the market. The Global Piriformis Syndrome Market is projected to reach 171.9 USD Million by 2024, reflecting the urgent need for effective treatment options and management strategies.

Growing Demand for Rehabilitation Services

The increasing demand for rehabilitation services for individuals suffering from Piriformis Syndrome Market is a crucial driver for the Global Piriformis Syndrome Market Industry. Rehabilitation programs focusing on physical therapy, exercise regimens, and pain management are becoming more prevalent. This trend is largely influenced by the rising number of patients seeking non-invasive treatment options. As healthcare systems prioritize rehabilitation to improve quality of life, the market is expected to expand significantly. The emphasis on holistic approaches to treatment aligns with the growing preference for personalized care, further supporting the market's development.

Market Segment Insights

By Treatment Type: Physical Therapy (Largest) vs. Medication (Fastest-Growing)

In the Piriformis Syndrome Market, the treatment type segment showcases a diverse array of options, with Physical Therapy holding the largest market share. This is primarily due to the rising acceptance of non-invasive treatment methods, which emphasize rehabilitation and recovery through carefully structured exercises. Medication, on the other hand, has shown significant growth potential as more patients seek immediate relief from pain through pharmaceuticals, particularly anti-inflammatory drugs and muscle relaxants. Growth trends in this market segment are being driven by increased awareness of Piriformis Syndrome and its effects on quality of life. As research continues to validate the efficacy of conservative treatments, Physical Therapy remains the stronghold while Medication is rapidly gaining ground. The emergence of novel drugs and the integration of telehealth for personalized medication management further fuel the expansion of this segment.

Physical Therapy (Dominant) vs. Medication (Emerging)

Physical Therapy is the dominant treatment for Piriformis Syndrome due to its foundational approach of addressing the root causes of pain through physical rehabilitation. It is often tailored to individual patient needs, focusing on exercises that enhance strength, flexibility, and overall function, which can lead to long-term relief. On the other hand, Medication presents an emerging option that complements physical treatment, providing patients with necessary pain relief and inflammation reduction. With advancements in pharmacological treatments and a shift towards more holistic management of pain, this segment is witnessing rapid innovation. These two modalities signify a comprehensive approach to managing Piriformis Syndrome, balancing immediate relief with long-term recovery strategies.

By Diagnosis Method: Physical Examination (Largest) vs. MRI Scan (Fastest-Growing)

In the Piriformis Syndrome Market, diagnosis methods such as Physical Examination have established a substantial presence, representing the largest share within this segment. While Physical Examination remains a critical component in assessing the condition's severity, MRI Scans are emerging as the method with the fastest growth rate. Their ability to provide detailed imaging of soft tissues has increased their utilization among healthcare professionals, leading to a notable shift toward advanced diagnostic techniques. The growth trends for diagnosis methods in the Piriformis Syndrome Market are driven by advances in imaging technology and the need for accurate diagnoses. MRI Scans, in particular, are benefiting from technological enhancements, enabling clearer and more precise visualizations. Simultaneously, awareness about the syndrome among practitioners and patients is boosting the adoption of various diagnostic methods, enhancing overall market dynamics and providing diverse options for clinical assessments.

Physical Examination (Dominant) vs. Nerve Conduction Study (Emerging)

The Physical Examination remains the dominant diagnosis method in the Piriformis Syndrome Market due to its accessibility, effectiveness, and cost-efficiency. This traditional method allows healthcare providers to assess the patient's physical condition and identify piriformis syndrome symptoms through basic tests and evaluations. On the other hand, the Nerve Conduction Study is an emerging technique gaining traction in diagnosing nerve-related issues associated with the syndrome. It involves testing the electrical conduction of nerves, helping in identifying nerve entrapment and related conditions. The growing emphasis on comprehensive diagnostic approaches is likely to position the Nerve Conduction Study as a valuable tool in the assessment arsenal for Piriformis Syndrome.

By Patient Demographics: Age Group (Largest) vs. Gender (Fastest-Growing)

In the Piriformis Syndrome Market, the distribution of patient demographics reveals that age group holds the largest share of patients suffering from this condition, primarily affecting individuals aged between 30-50 years. This demographic represents a significant portion of the total market due to their active lifestyles, which can contribute to the onset of piriformis syndrome. Gender also plays a crucial role, with a growing number of women being diagnosed, indicating an increasing recognition of the syndrome's prevalence among female patients.

Age Group (Dominant) vs. Gender (Emerging)

The age group segment, particularly individuals aged 30-50 years, proves to be the dominant force in the Piriformis Syndrome Market due to their higher likelihood of engaging in activities that can lead to irritation of the sciatic nerve. This age bracket is often characterized by physical jobs or hobbies that exacerbate the condition. Meanwhile, the gender segment is emerging, reflecting a noteworthy trend where women, historically underrepresented, are increasingly diagnosed with piriformis syndrome. Awareness and outreach programs are pivotal in identifying and treating this condition in women, leading to expected growth in female patient numbers in the near future.

By Severity Level: Mild (Largest) vs. Severe (Fastest-Growing)

The Piriformis Syndrome market is characterized by varying severity levels, with 'Mild' symptoms commanding the largest market share. This segment appeals to a broad demographic, as individuals often seek early intervention for manageable pain. The distribution among 'Moderate', 'Severe', 'Chronic', and 'Acute' levels reflects the nuanced understanding of patient needs, with 'Moderate' and 'Severe' also capturing significant attention due to their relative prevalence among affected individuals. 'Chronic' and 'Acute' categories, while vital, contribute to a smaller fraction of the market, indicating varied treatment complexities. Growth trends highlight an increasing focus on acute and severe Piriformis Syndrome cases, driven by heightened awareness and advancements in therapeutic options. Factors such as innovative treatment modalities, the rise of specialty clinics, and increased patient education have contributed to the swift growth of the severe category. Furthermore, the chronic nature of some cases continues to necessitate improvements in management strategies, promoting ongoing research and development in targeted therapies.

Mild (Dominant) vs. Severe (Emerging)

The 'Mild' severity level represents a dominant segment in the Piriformis Syndrome market, characterized by lower intensity symptoms that often lead patients to pursue conservative treatment options. Individuals in this category tend to experience occasional discomfort, resulting in a proactive approach to management through physiotherapy and lifestyle adjustments. In contrast, the 'Severe' segment is emerging as a critical focus for healthcare providers, driven by increasing awareness and more comprehensive treatment protocols. Patients experiencing severe symptoms often require more aggressive intervention, potentially including surgical options. This differentiation in severity shapes treatment pathways and patient engagement, influencing the overall market dynamics as stakeholders adapt to the evolving landscape.

By Healthcare Setting: Outpatient Clinic (Largest) vs. Hospital (Fastest-Growing)

The healthcare setting for the Piriformis Syndrome market is diverse, with outpatient clinics holding the largest share of the market. These clinics are pivotal in providing accessible treatments and quick interventions for patients suffering from piriformis syndrome. Hospitals also occupy a significant place in this landscape, but their market share is growing rapidly due to increasing recognition of more complex cases that require comprehensive care and advanced treatment options.

Outpatient Clinic (Dominant) vs. Hospital (Emerging)

Outpatient clinics serve as the dominant setting in the Piriformis Syndrome market, offering targeted interventions and a convenient environment for patients. Their personalized approach and emphasis on non-invasive treatments appeal to many individuals seeking relief. In contrast, hospitals, labeled as an emerging setting, are stepping up their game to cater to the more complex cases of piriformis syndrome. The increase in surgical interventions and integrated care protocols in hospitals is aimed at accommodating patients with multifaceted issues, driving their growth in this market.

Get more detailed insights about Piriformis Syndrome Market
Request Free Sample

Regional Insights

North America : Market Leader in Innovation

North America is poised to maintain its leadership in the Piriformis Syndrome market, holding a significant market share of 13.4% in 2024. The region's growth is driven by increasing awareness of the condition, advancements in medical technology, and a robust healthcare infrastructure. Regulatory support for innovative treatments and therapies further fuels demand, making it a key player in the global market. The United States stands out as the leading country, with major players like Medtronic, Johnson & Johnson, and Stryker driving competition. The presence of advanced healthcare facilities and a high prevalence of musculoskeletal disorders contribute to the market's expansion. As the region continues to innovate, it attracts investments aimed at enhancing treatment options for Piriformis Syndrome.

Europe : Emerging Market with Growth Potential

Europe is witnessing a growing interest in the Piriformis Syndrome market, with a market share of 8.6% in 2024. Factors such as an aging population, increased healthcare spending, and a focus on pain management are driving demand. Regulatory frameworks in countries like Germany and France are evolving to support innovative treatment options, enhancing market growth prospects across the region. Leading countries include Germany, France, and the UK, where key players like Smith & Nephew and Zimmer Biomet are actively involved. The competitive landscape is characterized by collaborations and partnerships aimed at developing advanced therapeutic solutions. As healthcare systems adapt to meet patient needs, the market is expected to expand significantly in the coming years.

Asia-Pacific : Emerging Powerhouse in Healthcare

The Asia-Pacific region is emerging as a significant player in the Piriformis Syndrome market, with a market share of 3.8% in 2024. The growth is driven by rising healthcare expenditures, increasing awareness of musculoskeletal disorders, and a growing population. Countries like China and India are investing heavily in healthcare infrastructure, which is expected to boost demand for effective treatment options in the coming years. China and Japan are leading the market, with a competitive landscape featuring both local and international players. Companies are focusing on expanding their product offerings and enhancing distribution channels to capture a larger market share. As the region continues to develop, it presents lucrative opportunities for growth in the Piriformis Syndrome market.

Middle East and Africa : Resource-Rich Frontier for Healthcare

The Middle East and Africa region is gradually emerging in the Piriformis Syndrome market, holding a market share of 1.0% in 2024. The growth is primarily driven by increasing healthcare investments, a rising prevalence of lifestyle-related disorders, and a focus on improving healthcare access. Governments are implementing policies to enhance healthcare infrastructure, which is expected to support market growth in the coming years. Leading countries in this region include South Africa and the UAE, where healthcare systems are evolving to meet patient needs. The competitive landscape is characterized by a mix of local and international players, with companies focusing on establishing a presence in the region. As healthcare continues to improve, the market for Piriformis Syndrome treatments is anticipated to grow steadily.

Piriformis Syndrome Market Regional Image

Key Players and Competitive Insights

The Piriformis Syndrome Market is characterized by a competitive landscape that is increasingly shaped by innovation, strategic partnerships, and a focus on patient-centric solutions. Key players such as Medtronic (US), Johnson & Johnson (US), and Stryker (US) are actively engaged in enhancing their product offerings and expanding their market presence. Medtronic (US) has positioned itself as a leader in neuromodulation therapies, which are crucial for managing pain associated with Piriformis Syndrome. Meanwhile, Johnson & Johnson (US) emphasizes a diversified portfolio that includes surgical instruments and advanced imaging technologies, aiming to streamline treatment processes. Stryker (US) focuses on integrating digital health solutions into its surgical products, thereby enhancing operational efficiency and patient outcomes. Collectively, these strategies contribute to a dynamic competitive environment, where innovation and operational excellence are paramount.In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and improve supply chain resilience. This approach is particularly relevant in the context of the Piriformis Syndrome Market, which is moderately fragmented, with several players vying for market share. The collective influence of these key players is significant, as they not only drive technological advancements but also set industry standards that smaller companies must adhere to.

In November Medtronic (US) announced the launch of a new neuromodulation device specifically designed for chronic pain management, including Piriformis Syndrome. This strategic move is expected to enhance Medtronic's market share by addressing unmet needs in pain management, thereby reinforcing its leadership position. The introduction of this device aligns with the growing trend towards personalized medicine, which is becoming increasingly important in the treatment of musculoskeletal disorders.

In October Johnson & Johnson (US) entered into a partnership with a leading telehealth provider to enhance remote patient monitoring capabilities for individuals suffering from Piriformis Syndrome. This collaboration is strategically significant as it not only expands Johnson & Johnson's digital health footprint but also facilitates better patient engagement and adherence to treatment protocols. The integration of telehealth solutions is likely to improve patient outcomes and streamline care delivery.

In September Stryker (US) acquired a small but innovative company specializing in AI-driven surgical planning tools. This acquisition is indicative of Stryker's commitment to integrating advanced technologies into its product offerings, which could potentially revolutionize surgical approaches for Piriformis Syndrome. By leveraging AI, Stryker aims to enhance precision in surgical procedures, thereby improving recovery times and overall patient satisfaction.

As of December the Piriformis Syndrome Market is witnessing trends that emphasize digitalization, sustainability, and the integration of AI technologies. Strategic alliances are increasingly shaping the competitive landscape, allowing companies to pool resources and expertise to drive innovation. The shift from price-based competition to a focus on technological advancement and supply chain reliability is evident. Moving forward, competitive differentiation will likely hinge on the ability to innovate and deliver superior patient outcomes, as companies navigate an evolving market landscape.

Key Companies in the Piriformis Syndrome Market include

Future Outlook

Piriformis Syndrome Market Future Outlook

The Piriformis Syndrome Market is projected to grow at a 6.59% CAGR from 2025 to 2035, driven by increasing awareness, innovative treatment options, and rising healthcare expenditures.

New opportunities lie in:

  • Development of telehealth platforms for remote consultations and treatment plans.
  • Investment in targeted physical therapy programs tailored for Piriformis Syndrome patients.
  • Creation of specialized ergonomic products to alleviate symptoms in workplaces.

By 2035, the Piriformis Syndrome Market is expected to achieve substantial growth and innovation.

Market Segmentation

Piriformis Syndrome Market Treatment Type Outlook

  • Physical Therapy
  • Medication
  • Surgery
  • Chiropractic Care
  • Massage Therapy

Piriformis Syndrome Market Diagnosis Method Outlook

  • Physical Examination
  • Imaging Techniques
  • Electromyography
  • Nerve Conduction Studies
  • Patient History

Piriformis Syndrome Market Symptom Severity Outlook

  • Mild
  • Moderate
  • Severe
  • Chronic
  • Acute

Piriformis Syndrome Market Patient Demographics Outlook

  • Age Group
  • Gender
  • Activity Level
  • Occupation
  • Health Status

Report Scope

MARKET SIZE 2024 0.268(USD Million)
MARKET SIZE 2025 0.289(USD Million)
MARKET SIZE 2035 0.544(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 6.59% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled Medtronic (US), Johnson & Johnson (US), Stryker (US), Boston Scientific (US), Abbott Laboratories (US), Smith & Nephew (GB), Zimmer Biomet (US), DePuy Synthes (US)
Segments Covered Treatment Type, Patient Demographics, Symptom Severity, Diagnosis Method
Key Market Opportunities Advancements in non-invasive treatment options for Piriformis Syndrome enhance patient outcomes and market potential.
Key Market Dynamics Rising demand for non-invasive treatment options drives innovation in the Piriformis Syndrome market.
Countries Covered North America, Europe, APAC, South America, MEA

Market Highlights

FAQs

What is the projected market valuation for the Piriformis Syndrome Market in 2035?

The projected market valuation for the Piriformis Syndrome Market in 2035 is expected to reach 0.544 USD Million.

What was the overall market valuation for the Piriformis Syndrome Market in 2024?

The overall market valuation for the Piriformis Syndrome Market in 2024 was 0.268 USD Million.

What is the expected CAGR for the Piriformis Syndrome Market during the forecast period 2025 - 2035?

The expected CAGR for the Piriformis Syndrome Market during the forecast period 2025 - 2035 is 6.59%.

Which companies are considered key players in the Piriformis Syndrome Market?

Key players in the Piriformis Syndrome Market include Medtronic, Johnson & Johnson, Stryker, and Boston Scientific.

What treatment type segment had the highest valuation in 2024?

In 2024, the Physical Therapy segment had the highest valuation at 0.1648 USD Million.

How does the market perform in terms of diagnosis methods for Piriformis Syndrome?

The MRI Scan segment shows a valuation of 0.174 USD Million, indicating strong performance in diagnosis methods.

What demographic factors are influencing the Piriformis Syndrome Market?

Factors such as Age Group and Gender are influencing the market, with valuations of 0.1 USD Million and 0.12 USD Million, respectively.

What is the market outlook for outpatient clinics in the Piriformis Syndrome Market?

The outpatient clinic segment is projected to maintain a valuation of 0.136 USD Million, reflecting its importance in healthcare settings.

Which severity level segment is expected to show growth in the coming years?

The Moderate severity level segment, valued at 0.162 USD Million, is expected to show growth in the coming years.

How does the Piriformis Syndrome Market compare across different healthcare settings?

In 2024, the Hospital segment led with a valuation of 0.164 USD Million, suggesting a preference for treatment in hospital settings.
Author
Author
Author Profile
Rahul Gotadki LinkedIn
Research Manager
He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.
Get In Touch
Leave a Comment
Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Customer Stories
Case Study Cover Image
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓